Cyklokapron Alternatives Compared
Cyklokapron | Tranexamic acid | Zoladex |
|
---|
Cyklokapron (tranexamic acid) | Tranexamic acid | Zoladex (goserelin) |
|
|||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Prescription only
Prescribed for Bleeding Disorder, Factor IX Deficiency, Hemophilia A. Cyklokapron may also be used for purposes not listed in this medication guide. |
Prescription only
Prescribed for Heavy Menstrual Bleeding, Melasma, Menstrual Disorders, Bleeding Disorder, Factor IX Deficiency, Hemophilia A. tranexamic acid may also be used for purposes not listed in this medication guide. View more |
Prescription only
Prescribed for Prostate Cancer, Breast Cancer - Palliative, Endometriosis, Bleeding Disorder. Zoladex may also be used for purposes not listed in this medication guide. |
Related suggestions Bleeding Disorder
Popular comparisons
|
|||||||||||||||||||||||
More about Cyklokapron (tranexamic acid) | More about Tranexamic acid | More about Zoladex (goserelin) | ||||||||||||||||||||||||
Generic Status | ||||||||||||||||||||||||||
No lower-cost generic available |
||||||||||||||||||||||||||
Ratings & Reviews | ||||||||||||||||||||||||||
Cyklokapron has an average rating of 7.0 out of 10 from a total of 8 ratings on Drugs.com. 50% of reviewers reported a positive effect, while 33% reported a negative effect. |
Tranexamic acid has an average rating of 6.9 out of 10 from a total of 270 ratings on Drugs.com. 62% of reviewers reported a positive effect, while 25% reported a negative effect. |
Zoladex has an average rating of 6.8 out of 10 from a total of 97 ratings on Drugs.com. 56% of reviewers reported a positive effect, while 19% reported a negative effect. |
||||||||||||||||||||||||
Drug Class | ||||||||||||||||||||||||||
Side Effects | ||||||||||||||||||||||||||
See also: Cyklokapron side effects in more detail. |
See also: tranexamic acid side effects in more detail. |
See also: Zoladex side effects in more detail. |
||||||||||||||||||||||||
Pricing and Coupons * Prices are without insurance | ||||||||||||||||||||||||||
View all Cyklokapron prices and generic prices |
View all tranexamic acid prices |
View all Zoladex prices |
||||||||||||||||||||||||
Dosage Form(s) Available | ||||||||||||||||||||||||||
|
|
|
||||||||||||||||||||||||
Brand Names | ||||||||||||||||||||||||||
Other tranexamic acid brands include: Lysteda | Cyklokapron, Lysteda | Other goserelin brands include: Zoladex 3-Month | ||||||||||||||||||||||||
Half Life The half-life of a drug is the time taken for the plasma concentration of a drug to reduce to half its original value. | ||||||||||||||||||||||||||
2 hours |
2 hours |
4.2 hours |
||||||||||||||||||||||||
CSA Schedule ** View glossary of terms | ||||||||||||||||||||||||||
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||||||||||||||||||
Pregnancy Category | ||||||||||||||||||||||||||
Category B
No proven risk in humans
See the full pregnancy warnings document. |
Category B
No proven risk in humans
See the full pregnancy warnings document. |
Category X
Not for use in pregnancy
See the full pregnancy warnings document. |
||||||||||||||||||||||||
Drug Interactions | ||||||||||||||||||||||||||
A total of 37 drugs are known to interact with Cyklokapron:
|
A total of 37 drugs are known to interact with tranexamic acid:
|
A total of 277 drugs are known to interact with Zoladex:
|
||||||||||||||||||||||||
Alcohol/Food/Lifestyle Interactions | ||||||||||||||||||||||||||
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
||||||||||||||||||||||||
Disease Interactions | ||||||||||||||||||||||||||
First Approval Date | ||||||||||||||||||||||||||
N/A |
April 15, 2019 |
December 29, 1989 |
||||||||||||||||||||||||
WADA Class View World Anti-Doping Agency classifications. | ||||||||||||||||||||||||||
N/A |
N/A |
|||||||||||||||||||||||||
More Information | ||||||||||||||||||||||||||
Patient resources | ||||||||||||||||||||||||||
Professional Resources | ||||||||||||||||||||||||||
Related Treatment Guide | ||||||||||||||||||||||||||
** The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.